In addition to the common lineage markers of CTCL, such as CD3, CD4 and CD8, we have assessed the expression of CD20 and CD30 in a total collection of 58 MF tissue specimens, which have been collected from 35 patients at different time points in the course of MF disease progression. This evidence concerns the gene CD4 and primary cutaneous T-cell non-Hodgkin lymphoma.